Author

N. S. Beesabathuni

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

C.-i. Hwang· 1 shared E. Lee· 1 shared J. Pena· 1 shared K. Ji· 1 shared L. Scampavia· 1 shared M. Kim· 1 shared P. Shah· 1 shared Q. Tian· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C.-i. Hwang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer

E. Lee, S. Archasappawat, K. Ji, J. Pena, V. Fernandez-Vega, R. Gangaraju, N. S. Beesabathuni, M. Kim, Q. Tian, P. Shah, L. Scampavia, T. Spicer, C.-i. Hwang

This study identifies BET inhibition as a potential therapy for BRCA2-deficient pancreatic cancer by showing it enhances autophagy-dependent cell death in these cells.

bioRxiv · May 30, 2023 · PreprintCancer Biology